Indomore 75 mg – Indomethacin IP Capsules

Indomore 75 mg is an oral pharmaceutical formulation containing Indomethacin IP 75 mg, supplied in capsule dosage form. The product is available in a 10×10 capsule pack, providing a total of 100 capsules.

Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and anti-inflammatory properties. It is used in the management of several painful inflammatory and musculoskeletal conditions, including rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, acute painful shoulder conditions and acute gouty arthritis.

With its established NSAID profile and 75 mg strength, Indomore can be positioned within pharmaceutical portfolios focused on pain management, inflammatory disorders, rheumatology and orthopedic care.

What Is Indomore 75 mg Used For?

Indomore contains indomethacin and is used to relieve pain and inflammation associated with several musculoskeletal and rheumatological conditions.

Indomethacin is indicated for moderate to severe rheumatoid arthritis, including acute flares of chronic disease, moderate to severe ankylosing spondylitis and moderate to severe osteoarthritis. It is also indicated for acute painful shoulder conditions such as bursitis and tendinitis and for acute gouty arthritis.

The medicine works primarily by reducing the production of prostaglandins involved in pain and inflammation. This makes indomethacin relevant for conditions where inflammatory pain and swelling are important components of the disease.

How Does Indomethacin Work?

Indomethacin inhibits cyclooxygenase enzymes involved in prostaglandin synthesis. Prostaglandins contribute to inflammation, pain and other inflammatory responses.

By reducing prostaglandin production, indomethacin helps decrease inflammation and provides analgesic effects. It therefore has an established role in the symptomatic management of inflammatory joint and musculoskeletal conditions.

Composition

Each capsule contains:

Indomethacin IP – 75 mg

Product Specifications

Key Product Highlights

• Contains Indomethacin IP 75 mg

• NSAID formulation with analgesic and anti-inflammatory activity

• Oral capsule dosage form

• Used in the management of inflammatory and painful musculoskeletal conditions

• Relevant to rheumatoid arthritis and osteoarthritis management

• Used in ankylosing spondylitis

• Used for acute painful shoulder conditions such as bursitis and tendinitis

• Used for acute gouty arthritis

• Convenient 10×10 capsule presentation

• Total pack quantity of 100 capsules

Therapeutic Applications

Rheumatoid Arthritis

Indomethacin is used for the management of moderate to severe rheumatoid arthritis, including acute exacerbations of chronic disease. It helps reduce inflammatory pain and associated symptoms.

Osteoarthritis

It is used for symptomatic management of moderate to severe osteoarthritis, helping reduce pain and inflammation associated with affected joints.

Ankylosing Spondylitis

Indomethacin is indicated for moderate to severe ankylosing spondylitis, an inflammatory condition primarily affecting the spine and sacroiliac joints.

Acute Painful Shoulder

Indomethacin may be used for acute painful shoulder conditions associated with bursitis and/or tendinitis, where inflammation contributes to pain and restricted movement.

Acute Gouty Arthritis

Indomethacin is also indicated for the treatment of acute gouty arthritis, helping manage the intense inflammatory pain associated with an acute gout attack.

B2B Pharma Portfolio Relevance

Indomore 75 mg can be considered for pharmaceutical portfolios focused on pain management, anti-inflammatory therapy, rheumatology and orthopedic care.

The product provides an indomethacin-based option for pharmaceutical businesses developing a focused range of medicines for inflammatory joint disorders and acute musculoskeletal conditions.

Its 75 mg strength and capsule dosage form make it a relevant addition to a specialized pharmaceutical portfolio serving appropriate healthcare channels.

Why Consider Indomore 75 mg?

Indomore offers a focused formulation based on an established NSAID with applications across several inflammatory and painful conditions.

Key portfolio characteristics include:

• Indomethacin 75 mg formulation

• NSAID-based therapeutic positioning

• Analgesic and anti-inflammatory activity

• Relevance to rheumatology

• Relevance to orthopedic care

• Application across multiple inflammatory musculoskeletal conditions

• Capsule dosage form

• 10×10 commercial presentation

• Suitable for specialized pharmaceutical portfolios

Packing Information

Dosage Form: Capsule

Strength: 75 mg

Packing: 10 × 10 Capsules

Total Quantity: 100 Capsules

The latest approved product specification should be referred to for final commercial, regulatory and ordering information.

Important Medical Information

Indomethacin is an NSAID associated with important gastrointestinal, cardiovascular and renal risks. NSAIDs can cause serious gastrointestinal bleeding, ulceration and perforation, and cardiovascular thrombotic events. The approved prescribing information recommends using the lowest effective dose for the shortest duration consistent with the patient's treatment goals.

Indomethacin should therefore be used under appropriate medical supervision and according to the approved prescribing information.

Ideal Pharmaceutical Portfolio Segments

Indomore 75 mg is relevant to:

• Rheumatology

• Orthopedic Care

• Pain Management

• Anti-Inflammatory Therapy

• Musculoskeletal Disorders

• Joint Pain Management

• Gout Management

Business Enquiry

For product availability, commercial information and pharmaceutical business enquiries related to Indomore 75 mg, contact Farlex Pharmaceuticals Pvt. Ltd.